Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules

Serrano, D., Johansson, H., Bertelsen, B.-E., Gandini, S., Mellgren, G., Thomas, P., Crew, K. D., Kumar, N. B., Macis, D., Aristarco, V., Guerrieri-Gonzaga, A., Lazzeroni, M., D’Amico, M., Buttiron-Webber, T., Briata, I. M., Spinaci, S., Galimberti, V., Vornik, L. A., Villar-Sanchez, E., … DeCensi, A. (2024). Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae183
Authors:
Davide Serrano
Harriet Johansson
Bjørn-Erik Bertelsen
Sara Gandini
Gunnar Mellgren
Parijatham S. Thomas
Katherine D. Crew
Nagi B. Kumar
Debora Macis
Valentina Aristarco
Aliana Guerrieri‐Gonzaga
Matteo Lazzeroni
Mauro D’Amico
Tania Buttiron-Webber
Irene Maria Briata
Stefano Spinaci
Viviana Galimberti
Lana A. Vornik
Eduardo Villar-Sanchez
PH Brown
Brandy M. Heckman-Stoddard
Éva Szabó
Bernardo Bonanni
Andrea DeCensi
Affiliated Authors:
Katherine D. Crew
Author Keywords:
breast cancer
biomarkers
dose-response relationship
drug dosing
drugs
estradiol
exemestane
preventive therapy
Publication Type:
Article
Unique ID:
10.1093/jnci/djae183
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: